MedTrace Logo

Genetics of Diabetes Audit and Research in Tayside Scotland (DOLORisk Dundee)

NCT02783469 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1915

Last updated 2021-07-16

Study results available
· View outcomes & findings →

Summary

In 1997, the global prevalence of diabetes was estimated to be 125 million and this has risen to around 400 million in 2015. In addition diabetes has a number of complications including heart disease, blindness, kidney failure and amputation. This represents a significant burden on healthcare services. Type 2 diabetes (T2D) is caused by a combination of genetic and environmental factors. The aim of GoDARTS is to recruit participants with T2D to a registry to provide a platform with which to investigate the genetics of T2D, its complications and response to treatment. This study will investigate the genetic basis of diabetic neuropathic pain.

Conditions

  • Diabetic Neuropathic Pain

Interventions

GENETIC

Identification of genetic causes of diabetic neuropathic pain

Sponsors & Collaborators

  • Wellcome Trust

    collaborator OTHER

  • Diabetes UK

    collaborator OTHER

  • University of Dundee

    lead OTHER

Principal Investigators

  • Colin Palmer, PhD · University of Dundee

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02783469 on ClinicalTrials.gov